End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.15 CNY | -3.12% | -9.84% | -42.85% |
02:30pm | Hualan Biological Vaccine Chairman Proposes Up to 200 Million Yuan Buyback | MT |
May. 16 | Hualan Biological Engineering's Blood Centers Get License to Operate | MT |
Sales 2022 | 845M 117M | Sales 2023 | 701M 96.68M | Capitalization | 1.86B 256M |
---|---|---|---|---|---|
Net income 2022 | 54M 7.45M | Net income 2023 | 19M 2.62M | EV / Sales 2022 | 1.58 x |
Net cash position 2022 | 653M 90.05M | Net cash position 2023 | 427M 58.88M | EV / Sales 2023 | 2.04 x |
P/E ratio 2022 |
36.5
x | P/E ratio 2023 |
96.2
x | Employees | 2,546 |
Yield 2022 |
0.26% | Yield 2023 |
0.1% | Free-Float | 60.61% |
1 day | -3.12% | ||
1 week | -9.84% | ||
Current month | -9.49% | ||
1 month | -14.06% | ||
3 months | -17.72% | ||
6 months | -43.34% | ||
Current year | -42.85% |
Managers | Title | Age | Since |
---|---|---|---|
Hai Liang Mo
CEO | Chief Executive Officer | 46 | 16-12-31 |
Jia Li
DFI | Director of Finance/CFO | 51 | 12-05-08 |
Xiang Lei
CHM | Chairman | 67 | 12-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Zhao Mei Chi
BRD | Director/Board Member | 53 | 22-01-20 |
Gong Zhang Yuan
BRD | Director/Board Member | 50 | 20-05-31 |
Xiang Lei
CHM | Chairman | 67 | 12-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 7.15 | -3.12% | 2 814 800 |
24-06-04 | 7.38 | -2.77% | 3,447,706 |
24-06-03 | 7.59 | -3.92% | 3,209,686 |
24-05-31 | 7.9 | +1.02% | 1,661,100 |
24-05-30 | 7.82 | -2.13% | 2,595,200 |
End-of-day quote Shenzhen S.E., June 04, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-42.85% | 150M | |
+8.66% | 5.03B | |
+28.46% | 2.21B | |
+34.03% | 2.11B | |
+30.17% | 1.82B | |
-16.99% | 1.5B | |
+68.34% | 1.03B | |
+0.69% | 1.02B | |
+14.05% | 970M | |
+21.05% | 893M |
- Stock Market
- Equities
- 301027 Stock